Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Diseases of the Thyroid

  Free Subscription

Articles published in Endocr J

Retrieve available abstracts of 173 articles:
HTML format

Single Articles

    July 2021
  1. KIHARA M, Miyauchi A, Hirokawa M, Masuoka H, et al
    Long-term outcomes of cytologically benign thyroid tumors: a retrospective analysis of 3,102 patients at a single institution.
    Endocr J. 2021 Jul 16. doi: 10.1507/endocrj.EJ21-0252.
    PubMed     Abstract available

  2. WATANABE D, Yagasaki H, Narusawa H, Saito T, et al
    Screening of frequent variants associated with congenital hypothyroidism: a comparison with next generation sequencing.
    Endocr J. 2021 Jul 8. doi: 10.1507/endocrj.EJ21-0353.
    PubMed     Abstract available

  3. ITO Y, Hirokawa M, Kousaka K, Ito M, et al
    Diagnosis and management of hyalinizing trabecular tumor of the thyroid: a single-institution experience.
    Endocr J. 2021 Jul 6. doi: 10.1507/endocrj.EJ21-0143.
    PubMed     Abstract available

  4. OBA T, Maeno K, Amitani M, Shimizu T, et al
    Prognostic significance of neutrophil-to-lymphocyte ratio for long-term outcomes in patients with poorly differentiated thyroid cancer.
    Endocr J. 2021 Jul 2. doi: 10.1507/endocrj.EJ21-0237.
    PubMed     Abstract available

    June 2021
  5. FUJISHIMA M, Miyauchi A, Ito Y, Kudo T, et al
    Evaluation of the diagnostic utility of the aminotransferase/lactate dehydrogenase ratio for the suspension of tissue specimens during thyroid surgery for the identification of parathyroid tissue.
    Endocr J. 2021 Jun 15. doi: 10.1507/endocrj.EJ21-0128.
    PubMed     Abstract available

  6. HAYASHI T, Akiyama N, Kanematsu R, Higuchi M, et al
    Potential role of mobile rapid on-site evaluation((R)) in thyroid fine-needle aspiration cytology to reduce delayed repeated aspiration.
    Endocr J. 2021 Jun 12. doi: 10.1507/endocrj.EJ21-0010.
    PubMed     Abstract available

  7. MAO Y, Huo Y, Li J, Zhao Y, et al
    circRPS28 (hsa_circ_0049055) is a novel contributor for papillary thyroid carcinoma by regulating cell growth and motility via functioning as ceRNA for miR-345-5p to regulate frizzled family receptor 8 (FZD8).
    Endocr J. 2021 Jun 10. doi: 10.1507/endocrj.EJ21-0072.
    PubMed     Abstract available

  8. HANAI S, Uchimura K, Takahashi K, Ishii T, et al
    Hypoxia-induced thyroid hormone receptor expression regulates cell-cycle progression in renal tubule epithelial cells.
    Endocr J. 2021 Jun 8. doi: 10.1507/endocrj.EJ21-0245.
    PubMed     Abstract available

  9. LI X, Yang S, Zhao C, Yang J, et al
    CircHACE1 functions as a competitive endogenous RNA to curb differentiated thyroid cancer progression by upregulating Tfcp2L1 through adsorbing miR-346.
    Endocr J. 2021 Jun 4. doi: 10.1507/endocrj.EJ20-0806.
    PubMed     Abstract available

    May 2021
  10. OKADA J, Isoda A, Hoshi H, Watanabe T, et al
    Free triiodothyronine /free thyroxine ratio as an index of deiodinase type 1 and 2 activities negatively correlates with casual serum insulin levels in patients with type 2 diabetes mellitus.
    Endocr J. 2021 May 11. doi: 10.1507/endocrj.EJ21-0169.
    PubMed     Abstract available

  11. KAKUDO K, Liu Z, Bai Y, Li Y, et al
    How to identify indolent thyroid tumors unlikely to recur and cause cancer death immediately after surgery-Risk stratification of papillary thyroid carcinoma in young patients.
    Endocr J. 2021 May 11. doi: 10.1507/endocrj.EJ21-0018.
    PubMed     Abstract available

  12. MIZOKAMI T, Hamada K, Maruta T, Higashi K, et al
    Utility of outpatient fractionated radioiodine therapy for Graves disease involving a large goiter measuring more than 100 mL in volume.
    Endocr J. 2021 May 11. doi: 10.1507/endocrj.EJ20-0836.
    PubMed     Abstract available

  13. IIJIMA T, Jojima T, Hosonuma S, Ohhira E, et al
    Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome 22q11.2 deletion syndrome complicated by Graves' disease: longitudinal changes in the number of subsets of CD4 and CD8 lymphocytes after thyroidectomy.
    Endocr J. 2021 May 11. doi: 10.1507/endocrj.EJ20-0717.
    PubMed     Abstract available

    April 2021
  14. DING X, Zhao Y, Zhu CY, Wu LP, et al
    The association between subclinical hypothyroidism and metabolic syndrome: an update meta-analysis of observational studies.
    Endocr J. 2021 Apr 21. doi: 10.1507/endocrj.EJ20-0796.
    PubMed     Abstract available

  15. SAKAMOTO A, Hirokawa M, Ito M, Naganuma H, et al
    Introduction of histological classification and cytology reporting format of the Japanese General Rules for the Description of Thyroid Cancer with a special focus on the differences of the WHO Histological Classification and The Bethesda System of Thy
    Endocr J. 2021 Apr 13. doi: 10.1507/endocrj.EJ21-0077.
    PubMed     Abstract available

  16. TAGAMI T
    An overview of thyroid function tests in subjects with resistance to thyroid hormone and related disorders.
    Endocr J. 2021 Apr 6. doi: 10.1507/endocrj.EJ21-0059.
    PubMed     Abstract available

    March 2021
  17. HORIGUCHI K, Yoshida Y, Iwaku K, Emoto N, et al
    Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults.
    Endocr J. 2021 Mar 23. doi: 10.1507/endocrj.EJ20-0692.
    PubMed     Abstract available

  18. ITO Y, Hirokawa M, Fujishima M, Masuoka H, et al
    Prognostic significance of vascular invasion and cell-proliferation activity in widely invasive follicular carcinoma of the thyroid.
    Endocr J. 2021 Mar 20. doi: 10.1507/endocrj.EJ21-0064.
    PubMed     Abstract available

  19. LIU Y, Chen G, Wang B, Wu H, et al
    Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
    Endocr J. 2021 Mar 13. doi: 10.1507/endocrj.EJ20-0726.
    PubMed     Abstract available

  20. SHIMATSU A, Nakamura A, Takahashi Y, Fujio S, et al
    Preoperative and long-term efficacy and safety of lanreotide autogel in patients with thyrotropin-secreting pituitary adenoma: a multicenter, single-arm, phase 3 study in Japan.
    Endocr J. 2021 Mar 11. doi: 10.1507/endocrj.EJ20-0707.
    PubMed     Abstract available

    February 2021
  21. WANG D, Zheng Y
    Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Endocr J. 2021 Feb 20. doi: 10.1507/endocrj.EJ20-0353.
    PubMed     Abstract available

  22. TANIMURA Y, Kiriya M, Kawashima A, Mori H, et al
    Regulation of solute carrier family 26 member 7 (Slc26a7) by thyroid stimulating hormone in thyrocytes.
    Endocr J. 2021 Feb 14. doi: 10.1507/endocrj.EJ20-0502.
    PubMed     Abstract available

  23. NISHIHARA E, Ito Y, Kudo T, Ito M, et al
    Favorable outcomes of papillary thyroid microcarcinoma concurrent with Graves' disease after radioactive iodine therapy.
    Endocr J. 2021 Feb 6. doi: 10.1507/endocrj.EJ20-0753.
    PubMed     Abstract available

    January 2021
  24. FUKUDA N, Toda K, Wang X, Ohmoto A, et al
    Prognostic significance of 8 weeks' relative dose intensity of lenvatinib in treatment of radioiodine-refractory differentiated thyroid cancer patients.
    Endocr J. 2021 Jan 28. doi: 10.1507/endocrj.EJ20-0754.
    PubMed     Abstract available

  25. YAMADA Y, Orita M, Matsunaga H, Yamaguchi T, et al
    Risk perception regarding implementation of iodine thyroid blocking during a nuclear disaster of mothers living near a nuclear power station in Japan.
    Endocr J. 2021 Jan 21. doi: 10.1507/endocrj.EJ20-0627.
    PubMed     Abstract available

  26. DAMIAO CP, Montero JRG, Moran MBH, de Oliveira Marcal E Silva Carvalho ME, et al
    Application of thermography in the diagnostic investigation of thyroid nodules.
    Endocr J. 2021 Jan 21. doi: 10.1507/endocrj.EJ20-0541.
    PubMed     Abstract available

  27. MA J, Kan Z
    Circular RNA circ_0008274 enhances the malignant progression of papillary thyroid carcinoma via modulating solute carrier family 7 member 11 by sponging miR-154-3p.
    Endocr J. 2021 Jan 19. doi: 10.1507/endocrj.EJ20-0453.
    PubMed     Abstract available

  28. SPEER G, Somogyi P
    Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).
    Endocr J. 2021 Jan 19. doi: 10.1507/endocrj.EJ20-0443.
    PubMed     Abstract available

  29. WATANABE T, Temma Y, Okada J, Yamada E, et al
    In patients with type 2 diabetes the presence of Hashimoto's thyroiditis reduces the beneficial effect of dipeptidyl peptidase-4 inhibitor on plasma glucose control.
    Endocr J. 2021 Jan 7. doi: 10.1507/endocrj.EJ20-0620.
    PubMed     Abstract available

    December 2020
  30. TAKESHIMA K, Li Y, Kakudo K, Hirokawa M, et al
    Proposal of diagnostic criteria for IgG4-related thyroid disease.
    Endocr J. 2020 Dec 12. doi: 10.1507/endocrj.EJ20-0557.
    PubMed     Abstract available

    November 2020
  31. TAKAHASHI S, Ito M, Masaki Y, Hada M, et al
    Association between serum thyroid hormone balance and thyroid volume in patients treated with levothyroxine monotherapy for hypothyroidism.
    Endocr J. 2020 Nov 25. doi: 10.1507/endocrj.EJ20-0542.
    PubMed     Abstract available

  32. MIZUNO S, Inaba H, Kobayashi KI, Kubo K, et al
    A case of postpartum thyroiditis following SARS-CoV-2 infection.
    Endocr J. 2020 Nov 12. doi: 10.1507/endocrj.EJ20-0553.
    PubMed     Abstract available

    October 2020
  33. YUAN X, Wang J, Gao Y, Wang H, et al
    Impact of maternal thyroid hormone in late pregnancy on adverse birth outcomes: A retrospective cohort study in China.
    Endocr J. 2020 Oct 27. doi: 10.1507/endocrj.EJ20-0377.
    PubMed     Abstract available

  34. LI S, Li W, Sheng B, Zhu X, et al
    Relationship between thyroid disorders and uterine fibroids among reproductive-age women.
    Endocr J. 2020 Oct 8. doi: 10.1507/endocrj.EJ20-0340.
    PubMed     Abstract available

  35. INABA H, Ariyasu H, Iwakura H, Kurimoto C, et al
    Distinct clinical features and prognosis between persistent and temporary thyroid dysfunctions by immune-checkpoint inhibitors.
    Endocr J. 2020 Oct 3. doi: 10.1507/endocrj.EJ20-0371.
    PubMed     Abstract available

  36. TSUNEMI A, Uchida T, Kuroda K, Ikemoto Y, et al
    Effect of thyroxine treatment on pregnancy outcomes in infertile Japanese women with TSH levels between 2.5 muIU/mL and the upper reference limit: a retrospective study.
    Endocr J. 2020 Oct 1. doi: 10.1507/endocrj.EJ20-0380.
    PubMed     Abstract available

    September 2020
  37. TAKAGI S, Hirokawa M, Nagashima K, Higuchi M, et al
    Diagnostic significance of apical membranous and cytoplasmic dot-like CD26 expression in encapsulated follicular variant of papillary thyroid carcinoma: a useful marker for capsular invasion.
    Endocr J. 2020 Sep 2. doi: 10.1507/endocrj.EJ19-0501.
    PubMed     Abstract available

    August 2020
  38. ISHIHARA S, Onoda N, Noda S, Tauchi Y, et al
    Treatment of anaplastic thyroid cancer with tyrosine kinase inhibitors targeted on the tumor vasculature: initial experience in clinical practice.
    Endocr J. 2020 Aug 29. doi: 10.1507/endocrj.EJ20-0287.
    PubMed     Abstract available

  39. SAKAMOTO A, Matsuzuka T, Yamaya Y, Suzuki S, et al
    Cytological examination of the thyroid in children and adolescents after the Fukushima Nuclear Power Plant accident: the Fukushima Health Management Survey.
    Endocr J. 2020 Aug 20. doi: 10.1507/endocrj.EJ20-0235.
    PubMed     Abstract available

  40. SUGIYAMA K, Kobayashi S, Kurihara I, Miyashita K, et al
    Effect of long-term amiodarone treatment on thyroid function in euthyroid Japanese patients: a 12-month retrospective analysis.
    Endocr J. 2020 Aug 18. doi: 10.1507/endocrj.EJ20-0307.
    PubMed     Abstract available

  41. OBA T, Chino T, Soma A, Shimizu T, et al
    Comparative efficacy and safety of tyrosine kinase inhibitors for thyroid cancer: a systematic review and meta-analysis.
    Endocr J. 2020 Aug 18. doi: 10.1507/endocrj.EJ20-0171.
    PubMed     Abstract available

    July 2020
  42. YI W, Kim BH, Kim M, Ryang SR, et al
    Short-term bone marrow suppression in differentiated thyroid cancer patients after radioactive iodine treatment.
    Endocr J. 2020 Jul 28. doi: 10.1507/endocrj.EJ20-0242.
    PubMed     Abstract available

  43. OSHITA M, Ito Y, Miyamoto T, Ota H, et al
    Ultrasound findings of noninvasive follicular thyroid neoplasm with papillary-like nuclear features compared with those of follicular variant of papillary carcinoma and encapsulated papillary carcinoma: a single-institution study in Japan.
    Endocr J. 2020 Jul 16. doi: 10.1507/endocrj.EJ20-0254.
    PubMed     Abstract available

  44. PACE C, Tumino D, Russo M, Le Moli R, et al
    Role of selenium and myo-inositol supplementation on autoimmune thyroiditis progression.
    Endocr J. 2020 Jul 15. doi: 10.1507/endocrj.EJ20-0062.
    PubMed     Abstract available

  45. HIROKAWA M, Suzuki A, Hashimoto Y, Satoh S, et al
    Prevalence and diagnostic challenges of thyroid lymphoma: a multi-institutional study in non-Western countries.
    Endocr J. 2020 Jul 9. doi: 10.1507/endocrj.EJ20-0202.
    PubMed     Abstract available

    June 2020
  46. HIROKAWA M, Higuchi M, Suzuki A, Hayashi T, et al
    Prevalence and diagnostic significance of noninvasive follicular thyroid neoplasm with papillary-like nuclear features among tumors previously diagnosed as follicular adenoma: a single-institutional study in Japan.
    Endocr J. 2020 Jun 26. doi: 10.1507/endocrj.EJ20-0198.
    PubMed     Abstract available

  47. ITO Y, Hirokawa M, Hayashi T, Ota H, et al
    Case report: exceptionally rapid growth character of hobnail variant of papillary thyroid carcinoma: a report of four cases.
    Endocr J. 2020 Jun 18. doi: 10.1507/endocrj.EJ20-0248.
    PubMed     Abstract available

  48. TAKESHIMA K, Ariyasu H, Uraki S, Morita S, et al
    False-positive staining of thyroglobulin distinguished from mixed medullary and follicular thyroid carcinoma by duplex in situ hybridization.
    Endocr J. 2020 Jun 10. doi: 10.1507/endocrj.EJ20-0169.
    PubMed     Abstract available

  49. SUZUKI N, Yoshihara A, Yoshimura Noh J, Kinoshita K, et al
    TRAb elevations occurred even in the third trimester; a case of a mother of a child with neonatal thyroid dysfunction, who received radioactive iodine therapy for Graves' disease.
    Endocr J. 2020 Jun 10. doi: 10.1507/endocrj.EJ20-0039.
    PubMed     Abstract available

    May 2020
    Impact of gross extrathyroidal extension into major neck structures on the prognosis of papillary thyroid carcinoma according to the American Joint Committee on Cancer eighth edition.
    Endocr J. 2020 May 28. doi: 10.1507/endocrj.EJ19-0523.
    PubMed     Abstract available

  51. OTSUKI N, Shimoda H, Morita N, Furukawa T, et al
    Salvage surgery for structural local recurrence of papillary thyroid cancer: recurrence patterns and surgical outcome.
    Endocr J. 2020 May 27. doi: 10.1507/endocrj.EJ20-0152.
    PubMed     Abstract available

  52. DAI H, Zhang L, Han X, Zhao H, et al
    Body mass index (BMI) is associated with serum thyroid-stimulating hormone (TSH) level in infertile women: a cross-sectional study.
    Endocr J. 2020 May 15. doi: 10.1507/endocrj.EJ19-0441.
    PubMed     Abstract available

    April 2020
  53. MATSUZU K, Sugino K, Masudo K, Mori K, et al
    Clinical outcomes and risk stratification for papillary thyroid carcinoma presenting with distant metastasis before the era of tyrosine kinase inhibitors.
    Endocr J. 2020 Apr 28. doi: 10.1507/endocrj.EJ20-0081.
    PubMed     Abstract available

  54. KO J, Kim JY, Kim JW, Yoon JS, et al
    Anti-oxidative and anti-adipogenic effects of caffeine in an in vitro model of Graves' orbitopathy.
    Endocr J. 2020;67:439-447.
    PubMed     Abstract available

  55. INAGAKI Y, Takeshima K, Nishi M, Ariyasu H, et al
    The influence of thyroid autoimmunity on pregnancy outcome in infertile women: a prospective study.
    Endocr J. 2020 Apr 25. doi: 10.1507/endocrj.EJ19-0604.
    PubMed     Abstract available

  56. CHUNG JH
    BRAF and TERT promoter mutations: clinical application in thyroid cancer.
    Endocr J. 2020 Apr 21. doi: 10.1507/endocrj.EJ20-0063.
    PubMed     Abstract available

  57. ITO Y, Onoda N, Okamoto T
    The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer.
    Endocr J. 2020 Apr 9. doi: 10.1507/endocrj.EJ20-0025.
    PubMed     Abstract available

  58. OKAMURA K, Bandai S, Fujikawa M, Sato K, et al
    Clinical experience of treating Graves' hyperthyroidism complicated with malignancy-The possible role of potassium iodide for avoiding the risk of thionamide-associated neutropenia.
    Endocr J. 2020 Apr 2. doi: 10.1507/endocrj.EJ20-0016.
    PubMed     Abstract available

    March 2020
  59. CHEN Y, Tai HY
    Levothyroxine in the treatment of overt or subclinical hypothyroidism: a systematic review and meta-analysis.
    Endocr J. 2020 Mar 31. doi: 10.1507/endocrj.EJ19-0583.
    PubMed     Abstract available

  60. PAPANIKOLAOU A, Katsamakas M, Boudina M, Pamporaki C, et al
    Intrathyroidal parathyroid adenoma mimicking thyroid cancer.
    Endocr J. 2020 Mar 26. doi: 10.1507/endocrj.EJ19-0594.
    PubMed     Abstract available

  61. SUZUKI N, Yoshimura Noh J, Sugisawa C, Hoshiyama A, et al
    Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves' disease.
    Endocr J. 2020 Mar 18. doi: 10.1507/endocrj.EJ19-0379.
    PubMed     Abstract available

  62. ZHOU J, Dong X, Liu Y, Jia Y, et al
    Gestational hypothyroidism elicits more pronounced lipid dysregulation in mice than pre-pregnant hypothyroidism.
    Endocr J. 2020 Mar 10. doi: 10.1507/endocrj.EJ19-0455.
    PubMed     Abstract available

    February 2020
  63. ZHU XH, Zhou JN, Qian YY, Yang K, et al
    Diagnostic values of thyroglobulin in lymph node fine-needle aspiration washout: a systematic review and meta-analysis diagnostic values of FNA-Tg.
    Endocr J. 2020;67:113-123.
    PubMed     Abstract available

  64. SHIMAZAKI S, Kazukawa I, Mori K, Kihara M, et al
    Factors predicting endocrine late effects in childhood cancer survivors from a Japanese hospital.
    Endocr J. 2020;67:131-140.
    PubMed     Abstract available

  65. OKAMOTO M, Watanabe M, Inoue N, Ogawa K, et al
    Gene polymorphisms of VEGF and VEGFR2 are associated with the severity of Hashimoto's disease and the intractability of Graves' disease, respectively.
    Endocr J. 2020 Feb 20. doi: 10.1507/endocrj.EJ19-0480.
    PubMed     Abstract available

  66. NISHIHARA E, Kudo T, Ito M, Fukata S, et al
    Papillary thyroid carcinomas are highly obscured by inflammatory hypoechoic regions caused by subacute thyroiditis: a longitudinal evaluation of 710 patients using ultrasonography.
    Endocr J. 2020 Feb 15. doi: 10.1507/endocrj.EJ19-0597.
    PubMed     Abstract available

    January 2020
  67. UCHIDA T, Yamaguchi H, Kushima C, Yonekawa T, et al
    Elevated levels of circulating fibroblast growth factor 23 with hypercalcemia following discontinuation of denosumab.
    Endocr J. 2020;67:31-35.
    PubMed     Abstract available

  68. OHASHI R
    Solid variant of papillary thyroid carcinoma: an under-recognized entity.
    Endocr J. 2020 Jan 25. doi: 10.1507/endocrj.EJ19-0414.
    PubMed     Abstract available

  69. OHBA K, Okada E, Goto Y, Suzuki S, et al
    Influence of thyroid dysfunction on brain natriuretic peptide level in health examination participants.
    Endocr J. 2020 Jan 18. doi: 10.1507/endocrj.EJ19-0380.
    PubMed     Abstract available

    December 2019
  70. HIROMATSU Y, Eguchi H, Matsuo Y, Kato T, et al
    Role of a new bioassay for thyroid-stimulating antibodies (aequorin TSAb) in Graves' ophthalmopathy.
    Endocr J. 2019 Dec 10. doi: 10.1507/endocrj.EJ19-0398.
    PubMed     Abstract available

  71. CHEN Z, Wang Y, Ding X, Zhang M, et al
    The proportion of peripheral blood Tregs among the CD4+ T cells of autoimmune thyroid disease patients: a meta-analysis.
    Endocr J. 2019 Dec 10. doi: 10.1507/endocrj.EJ19-0307.
    PubMed     Abstract available

  72. SANTRAC N, Markovic I, Medic Milijic N, Goran M, et al
    Sentinel lymph node biopsy in medullary thyroid microcarcinomas.
    Endocr J. 2019 Dec 3. doi: 10.1507/endocrj.EJ19-0409.
    PubMed     Abstract available

    November 2019
  73. ITO Y, Miyauchi A, Yamamoto M, Masuoka H, et al
    Subset analysis of the Japanese risk classification guidelines for papillary thyroid carcinoma.
    Endocr J. 2019 Nov 27. doi: 10.1507/endocrj.EJ19-0387.
    PubMed     Abstract available

  74. FUJIMOTO N, Matsuu-Matsuyama M, Nakashima M
    Morphological and functional changes in neonatally X-irradiated thyroid gland in rats.
    Endocr J. 2019 Nov 19. doi: 10.1507/endocrj.EJ19-0245.
    PubMed     Abstract available

    October 2019
  75. HOZUMI K, Fukuoka H, Odake Y, Takeuchi T, et al
    Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1.
    Endocr J. 2019;66:853-857.
    PubMed     Abstract available

  76. OHBA K, Maekawa M, Iwahara K, Suzuki Y, et al
    Abnormal thyroid hormone response to TRH in a case of macro-TSH and the cut-off value for screening cases of inappropriate TSH elevation.
    Endocr J. 2019 Oct 24. doi: 10.1507/endocrj.EJ19-0320.
    PubMed     Abstract available

    September 2019
  77. SUZUKI A, Hirokawa M, Higashiyama T, Fukata S, et al
    Flow cytometric, gene rearrangement, and karyotypic analyses of 110 cases of primary thyroid lymphoma: a single-institutional experience in Japan.
    Endocr J. 2019 Sep 3. doi: 10.1507/endocrj.EJ18-0348.
    PubMed     Abstract available

    August 2019
  78. INABA H, Ariyasu H, Takeshima K, Iwakura H, et al
    Comprehensive research on thyroid diseases associated with autoimmunity: autoimmune thyroid diseases, thyroid diseases during immune-checkpoint inhibitors therapy, and immunoglobulin-G4-associated thyroid diseases.
    Endocr J. 2019 Aug 20. doi: 10.1507/endocrj.EJ19-0234.
    PubMed     Abstract available

    Correlation of radioiodine doses for 6-hr and 24-hour iodine-131 thyroid uptake values for Graves' hyperthyroidism.
    Endocr J. 2019 Aug 7. doi: 10.1507/endocrj.EJ19-0199.
    PubMed     Abstract available

  80. LI S, Yun M, Tian L, Wu P, et al
    The injury of recurrent laryngeal nerve and thyroid regeneration after irreversible electroporation ablation of most part of thyroid gland-an experimental study on swine model.
    Endocr J. 2019 Aug 7. doi: 10.1507/endocrj.EJ19-0095.
    PubMed     Abstract available

    July 2019
  81. ARIMA H, Iwama S, Inaba H, Ariyasu H, et al
    Management of immune-related adverse events in endocrine organs induced by immune checkpoint inhibitors: clinical guidelines of the Japan Endocrine Society.
    Endocr J. 2019;66:581-586.
    PubMed     Abstract available

  82. DAGDEVIREN M, Ates I, Demir BF, Ergun E, et al
    Investigation of blood groups in benign thyroid diseases in Turkey.
    Endocr J. 2019 Jul 12. doi: 10.1507/endocrj.EJ18-0582.
    PubMed     Abstract available

  83. ITO M, Miyauchi A, Hisakado M, Yoshioka W, et al
    Thyroid function related symptoms during levothyroxine monotherapy in athyreotic patients.
    Endocr J. 2019 Jul 2. doi: 10.1507/endocrj.EJ19-0094.
    PubMed     Abstract available

    June 2019
  84. TANG Y, Zhu X, Feng H, Zhu L, et al
    An improved mouse model of Graves disease by once immunization with Ad-TSHR289.
    Endocr J. 2019 Jun 18. doi: 10.1507/endocrj.EJ19-0148.
    PubMed     Abstract available

  85. YU H, Zhang W, Shen C, Zhang H, et al
    Liver dysfunction induced by Levothyroxine Sodium Tablets (Euthyrox(R)) in a hypothyroid patient with Hashimoto's thyroiditis: case report and literature review.
    Endocr J. 2019 Jun 18. doi: 10.1507/endocrj.EJ19-0078.
    PubMed     Abstract available

  86. KAWASAKI M, Ito M, Danno H, Kousaka K, et al
    The association between thyroid hormone balance and thyroid volume in patients with Hashimoto thyroiditis.
    Endocr J. 2019 Jun 1. doi: 10.1507/endocrj.EJ19-0063.
    PubMed     Abstract available

    May 2019
  87. KOIZUMI Y, Hirooka M, Hiraoka A, Ochi H, et al
    Lenvatinib-induced thyroid abnormalities in unresectable hepatocellular carcinoma.
    Endocr J. 2019 May 30. doi: 10.1507/endocrj.EJ19-0140.
    PubMed     Abstract available

  88. GUO X, Chen X, Zhang C, Zhang J, et al
    Hyperinsulinemia and thyroid peroxidase antibody in Chinese patients with papillary thyroid cancer.
    Endocr J. 2019 May 22. doi: 10.1507/endocrj.EJ18-0358.
    PubMed     Abstract available

    April 2019
  89. KIM MJ, Kim SM, Lee EK, Hwangbo Y, et al
    Tumor doubling time predicts response to sorafenib in radioactive iodine-refractory differentiated thyroid cancer.
    Endocr J. 2019 Apr 19. doi: 10.1507/endocrj.EJ18-0488.
    PubMed     Abstract available

    March 2019
  90. BANDAI S, Okamura K, Fujikawa M, Sato K, et al
    The long-term follow-up of patients with thionamide-treated Graves' hyperthyroidism.
    Endocr J. 2019 Mar 28. doi: 10.1507/endocrj.EJ18-0418.
    PubMed     Abstract available

  91. MIYAKAWA Y, Takasawa K, Matsubara Y, Ihara K, et al
    Language delay and developmental catch-up would be a clinical feature of pseudohypoparathyroidism type 1A during childhood.
    Endocr J. 2019;66:215-221.
    PubMed     Abstract available

  92. YAN AR, Zhang X, Shen H, Zhou X, et al
    Urinary iodine is increased in papillary thyroid carcinoma but is not altered by regional population iodine intake status: a meta-analysis and implications.
    Endocr J. 2019 Mar 19. doi: 10.1507/endocrj.EJ18-0532.
    PubMed     Abstract available

  93. KOSHIKAWA T, Fujita N, Ueda N, Ota Y, et al
    Important cytological findings for distinction between follicular variant and conventional papillary thyroid carcinoma, including noninvasive follicular thyroid tumors with papillary-like nuclear features.
    Endocr J. 2019 Mar 14. doi: 10.1507/endocrj.EJ18-0525.
    PubMed     Abstract available

  94. UEDA K, Kiyota A, Tsuchida M, Okazaki M, et al
    Successful treatment of myxedema coma with a combination of levothyroxine and liothyronine.
    Endocr J. 2019 Mar 8. doi: 10.1507/endocrj.EJ18-0469.
    PubMed     Abstract available

  95. RAJABI S, Dehghan MH, Dastmalchi R, Jalali Mashayekhi F, et al
    The roles and role-players in thyroid cancer angiogenesis.
    Endocr J. 2019 Mar 6. doi: 10.1507/endocrj.EJ18-0537.
    PubMed     Abstract available

  96. ZHANG X, Li Y, Zhou X, Han X, et al
    Association between serum thyrotropin within the euthyroid range and obesity.
    Endocr J. 2019 Mar 5. doi: 10.1507/endocrj.EJ18-0140.
    PubMed     Abstract available

    February 2019
  97. WANG K, Liu F, Wu C, Liu Y, et al
    Cyclic Cushing's syndrome caused by neuroendocrine tumor: a case report.
    Endocr J. 2019;66:175-180.
    PubMed     Abstract available

  98. WEI H, Huang M, Fan J, Wang T, et al
    Intraoperative rapid aspiration cytological method for parathyroid glands identification and protection.
    Endocr J. 2019;66:135-141.
    PubMed     Abstract available

  99. NOJIRI T, Kurano M, Araki O, Nakawatari K, et al
    Serum autotaxin levels are associated with Graves' disease.
    Endocr J. 2019 Feb 27. doi: 10.1507/endocrj.EJ18-0451.
    PubMed     Abstract available

  100. YOSHIHARA A, Luo Y, Ishido Y, Usukura K, et al
    Inhibitory effects of methimazole and propylthiouracil on iodotyrosine deiodinase 1 in thyrocytes.
    Endocr J. 2019 Feb 27. doi: 10.1507/endocrj.EJ18-0380.
    PubMed     Abstract available

  101. ZAKE T, Skuja S, Kalere I, Konrade I, et al
    Upregulated tissue expression of T helper (Th) 17 pathogenic interleukin (IL)-23 and IL-1beta in Hashimoto's thyroiditis but not in Graves' disease.
    Endocr J. 2019 Feb 27. doi: 10.1507/endocrj.EJ18-0396.
    PubMed     Abstract available

  102. KAN S, Kizilgul M, Celik B, Beysel S, et al
    The effect of disease activity on thyroid nodules in patients with acromegaly.
    Endocr J. 2019 Feb 9. doi: 10.1507/endocrj.EJ18-0502.
    PubMed     Abstract available

    January 2019
  103. HUANG K, Xu Y, Yan S, Li T, et al
    Isolated effect of maternal thyroid-stimulating hormone, free thyroxine and antithyroid peroxidase antibodies in early pregnancy on gestational diabetes mellitus: a birth cohort study in China.
    Endocr J. 2019 Jan 24. doi: 10.1507/endocrj.EJ18-0340.
    PubMed     Abstract available

  104. ITO Y, Miyauchi A, Oda H, Masuoka H, et al
    Appropriateness of the revised Japanese guidelines' risk classification for the prognosis of papillary thyroid carcinoma: a retrospective analysis of 5,845 papillary thyroid carcinoma patients.
    Endocr J. 2019 Jan 9. doi: 10.1507/endocrj.EJ17-0061.
    PubMed     Abstract available

    December 2018
  105. SUGINO K, Nagahama M, Kitagawa W, Ohkuwa K, et al
    Change of surgical strategy for Graves' disease from subtotal thyroidectomy to total thyroidectomy: a single institutional experience.
    Endocr J. 2018 Dec 19. doi: 10.1507/endocrj.EJ18-0324.
    PubMed     Abstract available

  106. OIWA A, Minemura K, Nishio SI, Yamazaki M, et al
    Implications of thyroid autoimmunity in infertile women with subclinical hypothyroidism in the absence of both goiter and anti-thyroid antibodies: lessons from three cases.
    Endocr J. 2018 Dec 18. doi: 10.1507/endocrj.EJ18-0350.
    PubMed     Abstract available

    November 2018
  107. TANAKA A, Hirokawa M, Higuchi M, Kanematsu R, et al
    Optimal needle size for thyroid fine needle aspiration cytology.
    Endocr J. 2018 Nov 21. doi: 10.1507/endocrj.EJ18-0422.
    PubMed     Abstract available

    October 2018
  108. TAHARA M, Takami H, Ito Y, Sugino K, et al
    Cohort study exploring the effect of lenvatinib on differentiated thyroid cancer.
    Endocr J. 2018 Oct 24. doi: 10.1507/endocrj.EJ18-0261.
    PubMed     Abstract available

  109. HIGUCHI M, Hirokawa M, Kanematsu R, Tanaka A, et al
    Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.
    Endocr J. 2018 Oct 3. doi: 10.1507/endocrj.EJ18-0290.
    PubMed     Abstract available

    September 2018
  110. ADAMIDOU F, Anagnostis P, Boboridis K, Manani C, et al
    Enduring remission of active and sight-threatening Graves' orbitopathy with rituximab: report of two cases.
    Endocr J. 2018;65:963-967.
    PubMed     Abstract available

  111. SUZUKI A, Hirokawa M, Takada N, Higuchi M, et al
    Utility of monoclonal PAX8 antibody for distinguishing intrathyroid thymic carcinoma from follicular cell-derived thyroid carcinoma.
    Endocr J. 2018 Sep 12. doi: 10.1507/endocrj.EJ18-0282.
    PubMed     Abstract available

    August 2018
  112. CHEN CY, Chen ST, Huang BY, Hwang JS, et al
    The effect of suppressive thyroxine therapy in nodular goiter in postmenopausal women and 2 year's bone mineral density change.
    Endocr J. 2018 Aug 30. doi: 10.1507/endocrj.EJ18-0125.
    PubMed     Abstract available

  113. PASCHOU SA, Palioura E, Kothonas F, Myroforidis A, et al
    The effect of anti-TNF therapy on thyroid function in patients with inflammatory bowel disease.
    Endocr J. 2018 Aug 21. doi: 10.1507/endocrj.EJ18-0243.
    PubMed     Abstract available

  114. HIROKAWA M, Suzuki A, Miyauchi A
    Comment on: "Derivation of thyroid lymphoepithelial cysts from follicular cells".
    Endocr J. 2018 Aug 10. doi: 10.1507/endocrj.EJ18-0201.

  115. CHEN J, Zhou W, Pan F, Cui W, et al
    Age-related change in thyroid-stimulating hormone: a cross-sectional study in healthy euthyroid population.
    Endocr J. 2018 Aug 1. doi: 10.1507/endocrj.EJ18-0113.
    PubMed     Abstract available

    July 2018
  116. OKUMA H, Hashimoto K, Ohashi T, Mihara M, et al
    A case of TSH-secreting pituitary adenoma with cyclic fluctuations in serum TSH levels.
    Endocr J. 2018;65:737-746.
    PubMed     Abstract available

  117. BOTELHO IMB, Moura Neto A, Silva CA, Tambascia MA, et al
    Vitamin D in Hashimoto's thyroiditis and its relationship with thyroid function and inflammatory status.
    Endocr J. 2018 Jul 27. doi: 10.1507/endocrj.EJ18-0166.
    PubMed     Abstract available

  118. LONG W, Lu G, Zhou W, Yang Y, et al
    Targeted next-generation sequencing of thirteen causative genes in Chinese patients with congenital hypothyroidism.
    Endocr J. 2018 Jul 18. doi: 10.1507/endocrj.EJ18-0156.
    PubMed     Abstract available

  119. KAGEYAMA K, Sakihara S, Kameda W, Sugiyama A, et al
    Evaluation of growth hormone-releasing peptide-2 for diagnosis of thyrotropin-producing pituitary adenomas.
    Endocr J. 2018 Jul 5. doi: 10.1507/endocrj.EJ17-0527.
    PubMed     Abstract available

    June 2018
  120. LU Q, Luo X, Mao C, Zheng T, et al
    Caveolin-1 regulates autophagy activity in thyroid follicular cells and is involved in Hashimoto's thyroiditis disease.
    Endocr J. 2018 Jun 6. doi: 10.1507/endocrj.EJ18-0003.
    PubMed     Abstract available

    May 2018
  121. OMORI N, Watanabe M, Inoue N, Taniguchi J, et al
    Association of the polymorphisms in Th2 chemotaxis-related genes with the development and prognosis of autoimmune thyroid diseases.
    Endocr J. 2018 May 30. doi: 10.1507/endocrj.EJ18-0050.
    PubMed     Abstract available

  122. WADA M, Kita M, Kawasaki K, Kusakabe T, et al
    False-positive TSH receptor antibody-a pitfall of third-generation TSH receptor antibody measurements in neonates.
    Endocr J. 2018;65:587-592.
    PubMed     Abstract available

  123. HANEW K, Tanaka T, Horikawa R, Hasegawa T, et al
    Prevalence of diverse complications and its association with karyotypes in Japanese adult women with Turner syndrome-a questionnaire survey by the Foundation for Growth Science.
    Endocr J. 2018;65:509-519.
    PubMed     Abstract available

  124. TOMKINS M, Cavalcoli F, Stanley E, O'Rourke K, et al
    Autonomic alterations as a clinical manifestation of encephalopathy associated with autoimmune thyroid disease.
    Endocr J. 2018 May 25. doi: 10.1507/endocrj.EJ18-0035.
    PubMed     Abstract available

  125. TAKAMIZAWA T, Satoh T, Miyamoto T, Nakajima Y, et al
    Transducin beta-like 1, X-linked and nuclear receptor co-repressor cooperatively augment the ligand-independent stimulation of TRH and TSHbeta gene promoters by thyroid hormone receptors.
    Endocr J. 2018 May 23. doi: 10.1507/endocrj.EJ17-0384.
    PubMed     Abstract available

  126. LIU M, Li Z, Liang B, Li L, et al
    Hydrogen sulfide ameliorates rat myocardial fibrosis induced by thyroxine through PI3K/AKT signaling pathway.
    Endocr J. 2018 May 9. doi: 10.1507/endocrj.EJ17-0445.
    PubMed     Abstract available

    April 2018
  127. ITO Y, Miyauchi A, Hirokawa M, Yamamoto M, et al
    Prognostic value of the 8(th) edition of the tumor-node-metastasis classification for patients with papillary thyroid carcinoma: a single-institution study at a high-volume center in Japan.
    Endocr J. 2018 Apr 20. doi: 10.1507/endocrj.EJ18-0019.
    PubMed     Abstract available

  128. ITO Y, Miyauchi A, Hirokawa M, Yamamoto M, et al
    Prognostic value of the 8(th) tumor-node-metastasis classification for follicular carcinoma and poorly differentiated carcinoma of the thyroid in Japan.
    Endocr J. 2018 Apr 4. doi: 10.1507/endocrj.EJ17-0524.
    PubMed     Abstract available

    March 2018
  129. SUZUKI A, Hirokawa M, Ito A, Takada N, et al
    Derivation of thyroid lymphoepithelial cysts from follicular cells.
    Endocr J. 2018 Mar 14. doi: 10.1507/endocrj.EJ17-0402.
    PubMed     Abstract available

    February 2018
  130. OMI Y, Horiuchi K, Haniu K, Tokura M, et al
    Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case.
    Endocr J. 2018;65:245-252.
    PubMed     Abstract available

  131. TAKENOBU M, Moritani S, Yoshioka K, Morisaki T, et al
    A case report of thyroid metastasis from p16-positive oropharyngeal squamous cell carcinoma.
    Endocr J. 2018 Feb 15. doi: 10.1507/endocrj.EJ17-0553.
    PubMed     Abstract available

  132. HIROKAWA M, Takada N, Abe H, Suzuki A, et al
    Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia distinct from the salivary type.
    Endocr J. 2018 Feb 8. doi: 10.1507/endocrj.EJ17-0462.
    PubMed     Abstract available

    January 2018
  133. HIGUCHI T, Achmad A, Binh DD, Bhattarai A, et al
    Determining patient selection tool and response predictor for outpatient 30 mCi radioiodine ablation dose in non-metastatic differentiated thyroid carcinoma: a Japanese perspective.
    Endocr J. 2018 Jan 16. doi: 10.1507/endocrj.EJ17-0343.
    PubMed     Abstract available

  134. ARICI M, Oztas E, Yanar F, Aksakal N, et al
    Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients.
    Endocr J. 2018 Jan 11. doi: 10.1507/endocrj.EJ17-0162.
    PubMed     Abstract available

    December 2017
  135. SUGINO K, Nagahama M, Kitagawa W, Ohkuwa K, et al
    Clinical factors related to the efficacy of tyrosine kinase inhibitor therapy in radioactive iodine refractory recurrent differentiated thyroid cancer patients.
    Endocr J. 2017 Dec 21. doi: 10.1507/endocrj.EJ17-0365.
    PubMed     Abstract available

  136. SUN D, Zhou L, Wang S, Liu T, et al
    Effect of Di-(2-ethylhexyl) phthalate on the hypothalamus-pituitary-thyroid axis in adolescent rat.
    Endocr J. 2017 Dec 9. doi: 10.1507/endocrj.EJ17-0272.
    PubMed     Abstract available

  137. TAKADA N, Hirokawa M, Ohbayashi C, Nishikawa T, et al
    Re-evaluation of MIB-1 immunostaining for diagnosing hyalinizing trabecular tumour of the thyroid: semi-automated techniques with manual antigen retrieval are more accurate than fully automated techniques.
    Endocr J. 2017 Dec 2. doi: 10.1507/endocrj.EJ17-0413.
    PubMed     Abstract available

    November 2017
  138. HIROKAWA M, Nishihara E, Takada N, Higuchi M, et al
    Warthin-like papillary thyroid carcinoma with immunoglobulin G4-positive plasma cells possibly related to Hashimoto's thyroiditis.
    Endocr J. 2017 Nov 2. doi: 10.1507/endocrj.EJ17-0319.
    PubMed     Abstract available

    October 2017
  139. QU HJ, Qu XY, Hu Z, Lin Y, et al
    The synergic effect of BRAFV600E mutation and multifocality on central lymph node metastasis in unilateral papillary thyroid carcinoma.
    Endocr J. 2017 Oct 26. doi: 10.1507/endocrj.EJ17-0110.
    PubMed     Abstract available

  140. HE L, Shen C, Zhang Y, Chen Z, et al
    Evaluation of serum ferritin and thyroid function in the second trimester of pregnancy.
    Endocr J. 2017 Oct 13. doi: 10.1507/endocrj.EJ17-0253.
    PubMed     Abstract available

    September 2017
  141. HIROKAWA M, Higuchi M, Suzuki A, Hayashi T, et al
    Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institutional experience in Japan.
    Endocr J. 2017 Sep 12. doi: 10.1507/endocrj.EJ17-0214.
    PubMed     Abstract available

  142. SATOH M, Aso K, Nakayama T, Saji T, et al
    Effect of treatment with epoprostenol and endothelin receptor antagonists on the development of thyrotoxicosis in patients with pulmonary arterial hypertension.
    Endocr J. 2017 Sep 9. doi: 10.1507/endocrj.EJ17-0155.
    PubMed     Abstract available

  143. SUZUKI A, Hirokawa M, Takada N, Higuchi M, et al
    Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan.
    Endocr J. 2017 Sep 5. doi: 10.1507/endocrj.EJ17-0238.
    PubMed     Abstract available

  144. AOYAMA M, Takizawa H, Tsuboi M, Nakagawa Y, et al
    A case of metastatic follicular thyroid carcinoma complicated with Graves' disease after total thyroidectomy.
    Endocr J. 2017 Sep 5. doi: 10.1507/endocrj.EJ17-0220.
    PubMed     Abstract available

  145. NARUMI S, Fox LA, Fukudome K, Sakaguchi Z, et al
    Mild thyroid peroxidase deficiency caused by TPO mutations with residual activity: Correlation between clinical phenotypes and enzymatic activity.
    Endocr J. 2017 Sep 1. doi: 10.1507/endocrj.EJ17-0194.
    PubMed     Abstract available

    August 2017
  146. SAWA A, Chiba T, Ishii J, Yamamoto H, et al
    Effects of sorafenib and an adenylyl cyclase activator on in vitro growth of well-differentiated thyroid cancer cells.
    Endocr J. 2017 Aug 31. doi: 10.1507/endocrj.EJ16-0525.
    PubMed     Abstract available

  147. WU W, Gong X, Zhou Q, Chen X, et al
    US-guided percutaneous microwave ablation for the treatment of benign thyroid nodules.
    Endocr J. 2017 Aug 29. doi: 10.1507/endocrj.EJ17-0152.
    PubMed     Abstract available

  148. TOMARI S, Watanabe M, Inoue N, Mizuma T, et al
    The polymorphisms in the thyroid peroxidase gene were associated with the development of autoimmune thyroid disease and the serum levels of TPOAb.
    Endocr J. 2017 Aug 25. doi: 10.1507/endocrj.EJ17-0191.
    PubMed     Abstract available

  149. TAKADA N, Hirokawa M, Ito M, Ito A, et al
    Papillary thyroid carcinoma with desmoid-type fibromatosis: A clinical, pathological, and immunohistochemical study of 14 cases.
    Endocr J. 2017 Aug 10. doi: 10.1507/endocrj.EJ17-0242.
    PubMed     Abstract available

  150. BOGDANOVA TI, Saenko VA, Hirokawa M, Ito M, et al
    Comparative histopathological analysis of sporadic pediatric papillary thyroid carcinoma from Japan and Ukraine.
    Endocr J. 2017 Aug 10. doi: 10.1507/endocrj.EJ17-0134.
    PubMed     Abstract available

  151. NISHIHARA E, Amino N, Kudo T, Ito M, et al
    Comparison of thyroglobulin and thyroid peroxidase antibodies measured by five different kits in autoimmune thyroid diseases.
    Endocr J. 2017 Aug 2. doi: 10.1507/endocrj.EJ17-0164.
    PubMed     Abstract available

    July 2017
  152. HIROKAWA M, Kudo T, Ota H, Suzuki A, et al
    Preoperative diagnostic algorithm of primary thyroid lymphoma using ultrasound, aspiration cytology, and flow cytometry.
    Endocr J. 2017 Jul 8. doi: 10.1507/endocrj.EJ17-0111.
    PubMed     Abstract available

  153. HIROKAWA M, Miyauchi A, Kihara M, Kudo T, et al
    Chromophobe renal cell carcinoma-like thyroid carcinoma: A novel clinicopathologic entity possibly associated with tuberous sclerosis complex.
    Endocr J. 2017 Jul 6. doi: 10.1507/endocrj.EJ17-0096.
    PubMed     Abstract available

    June 2017
  154. MASAKI C, Sugino K, Saito N, Saito Y, et al
    Lenvatinib induces early tumor shrinkage in patients with advanced thyroid carcinoma.
    Endocr J. 2017 Jun 28. doi: 10.1507/endocrj.EJ17-0104.
    PubMed     Abstract available

  155. SUGISAWA C, Higuchi S, Takagi M, Hasegawa Y, et al
    Homozygous DUOXA2 mutation (p.Tyr138*) in a girl with congenital hypothyroidism and her apparently unaffected brother: Case report and review of the literature.
    Endocr J. 2017 Jun 16. doi: 10.1507/endocrj.EJ16-0564.
    PubMed     Abstract available

  156. TAKADA N, Hirokawa M, Suzuki A, Higuchi M, et al
    Reappraisal of "cyst fluid only" on thyroid fine-needle aspiration cytology.
    Endocr J. 2017 Jun 13. doi: 10.1507/endocrj.EJ17-0082.
    PubMed     Abstract available

  157. XIN W, Yu Y, Ma Y, Gao Y, et al
    Thyroid-stimulating hormone stimulation downregulates autophagy and promotes apoptosis in chondrocytes.
    Endocr J. 2017 Jun 13. doi: 10.1507/endocrj.EJ16-0534.
    PubMed     Abstract available

    May 2017
  158. INOUE N, Watanabe M, Nakaguchi A, Ueda D, et al
    Functional polymorphisms affecting Th1 differentiation are associated with the severity of autoimmune thyroid diseases.
    Endocr J. 2017 May 16. doi: 10.1507/endocrj.EJ16-0551.
    PubMed     Abstract available

    April 2017
  159. HIGUCHI S, Takagi M, Hasegawa Y
    Use of liothyronine without levothyroxine in the treatment of mild consumptive hypothyroidism caused by hepatic hemangiomas.
    Endocr J. 2017 Apr 18. doi: 10.1507/endocrj.EJ16-0559.
    PubMed     Abstract available

  160. KE W, Sun T, Zhang Y, He L, et al
    25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
    Endocr J. 2017 Apr 11. doi: 10.1507/endocrj.EJ16-0547.
    PubMed     Abstract available

    March 2017
  161. LI X, Zhen D, Zhao M, Liu L, et al
    Natural history of mild subclinical hypothyroidism in a middle-aged and elderly Chinese population: a prospective study.
    Endocr J. 2017 Mar 7. doi: 10.1507/endocrj.EJ16-0549.
    PubMed     Abstract available

  162. YALCIN MM, Altinova AE, Cavnar B, Bolayir B, et al
    Is thyroid autoimmunity itself associated with psychological well-being in euthyroid Hashimoto's thyroiditis?
    Endocr J. 2017 Mar 4. doi: 10.1507/endocrj.EJ16-0418.
    PubMed     Abstract available

    February 2017
  163. AKEHI Y, Hashimoto Y, Meren J, Tanabe M, et al
    Postpartum hypothalamic adrenal insufficiency with remission: A rare case.
    Endocr J. 2017;64:157-162.
    PubMed     Abstract available

  164. TAKANO T
    Natural history of thyroid cancer [Review].
    Endocr J. 2017 Feb 2. doi: 10.1507/endocrj.EJ17-0026.
    PubMed     Abstract available

    January 2017
  165. HIROKAWA M, Kudo T, Ota H, Suzuki A, et al
    Errata:Preoperative diagnostic algorithm of primary thyroid lymphoma using ultrasound, aspiration cytology, and flow cytometry [Endocrine Journal Vol. 64 (9): 859-865, 2017].
    Endocr J. 2017;64:1041-1042.
    PubMed     Abstract available

    December 2016
  166. KIM JW, Woo YJ, Yoon JS
    Is modified clinical activity score an accurate indicator of diplopia progression in Graves' orbitopathy patients?
    Endocr J. 2016;63:1133-1140.
    PubMed     Abstract available

  167. NOMURA R, Miyai K, Kuge R, Okura T, et al
    Free T3 to free T4 ratio less than 2.0 suggests low T3 syndrome rather than central hypothyroidism from the age of two to eighteen years.
    Endocr J. 2016 Dec 22. doi: 10.1507/endocrj.EJ16-0169.
    PubMed     Abstract available

    November 2016
  168. KOBAYASHI S, Yoshimura Noh J, Shimizu T, Sato T, et al
    A case of familial dysalbuminemic hyperthyroxinemia (FDH) in Japan: FDH as a possible differential diagnosis of syndrome of inappropriate secretion of thyroid-stimulating hormone (SITSH).
    Endocr J. 2016.
    PubMed     Abstract available

  169. ITO Y, Hirokawa M, Miyauchi A, Kihara M, et al
    Diagnosis and surgical indications of oxyphilic follicular tumors in Japan: Surgical specimens and cytology.
    Endocr J. 2016;63:977-982.
    PubMed     Abstract available

  170. HE Y, Mu K, Liu R, Zhang J, et al
    Comparison of two different regimens of intravenous methylprednisolone for patients with moderate to severe and active Graves' ophthalmopathy: a prospective, randomized controlled trial.
    Endocr J. 2016.
    PubMed     Abstract available

    October 2016
  171. SATOH T, Isozaki O, Suzuki A, Wakino S, et al
    2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition).
    Endocr J. 2016.
    PubMed     Abstract available

    September 2016
  172. ODA H, Miyauchi A, Ito Y, Sasai H, et al
    Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid.
    Endocr J. 2016.
    PubMed     Abstract available

    April 2016
  173. KAGAWA T, Watanabe M, Inoue N, Otsu H, et al
    Increases of microRNA let-7e in peripheral blood mononuclear cells in Hashimoto's disease.
    Endocr J. 2016;63:375-80.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.